Two-step Reactivation of Dormant Cones in Retinitis Pigmentosa

Slides:



Advertisements
Similar presentations
Research Perspectives and the Promise of Clinical Trials for Treatment of RP and Allied Diseases: ohenetihool L Gerald J. Chader, Ph.D., M.D.hc Doheny.
Advertisements

Stem Cells for Retinal Disease Roger F. Steinert, MDRoger F. Steinert, MD Irving H. Leopold Professor and ChairIrving H. Leopold Professor and Chair Professor.
Presenter: Juan Mo. Learning objectives What is gene therapy? What is a Dox-regulatable system and how can gene expression be regulated by Dox? What is.
80.3  The expression of mRNA for neurotrophins, and of their receptors is differentially upregulated after nerve injury  A strong role for BNDF, and.
UCL Institute of Ophthalmology Department of Genetics
Grand Rounds Peripheral Exudative Hemorrhagic Chorioretinopathy
0 0 Photobiomodulation The Healing Power of Light Janis T. Eells, Ph.D. Wisconsin Distinguished Professor.
By Jawad Braick.  Macular degeneration is progressive loss of vision to the point of legal blindness due to damage to the macula, the part of the eye.
Applications of ERG, mfERG & EOG
Grand Rounds Niloofar Piri, MD Jan 17th  CC: Blind spots and blurry vision OU for more than 2 years (OS more severely affected)  HPI: A 74-y Caucasian.
Current and Upcoming Clinical Trials Now, let’s consider 2 treatments where few or no photoreceptor cells remain alive. Possible treatments here would.
Stem Cell Notes IB Biology HL 1 Mrs. Peters Fall 2014.
Macular Degeneration Adult and Juvenile
Age-Related macular degeneration & retinitis pigmentosa Ayesha S abdullah
Stephanie Hunstable, Miranda Williams, Mandy Boyd, Anissa Lara & Cindy Anderson Macular Degeneration Region 11.
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
1 Testing sensory visual function. 2 types: 1) psychophysical tests 2) electrophysical tests.
Macular Degeneration John Fontenot Bridget Deckard Miriam Rios Brianne Korth Trenton Adkins.
 Stem Cells. Understandings  Specialized tissues can develop by cell differentiation in multicellular organisms.  Differentiation involves the expression.
Mobility Program Information on eye diseases and disorders was obtained at the St. Lukes Eye Clinic Website
Presented by Juan Mo. Study Questions Why zebrafish transgenetic lines are very important for studying photoreceptor degeneration? The synapses in inner.
Introduction Dry eye is a condition in which there are insufficient tears to lubricate and nourish the eye. An estimated 25 million Americans are affected.
,Waterloo Photoreceptor Topography in Aging and Age-related Maculopathy Christine A. Curcio, Ph.D. Department of Ophthalmology University of Alabama.
Visual Electrodiagnostic Testing-8 Mutez Gharaibeh,MD.
Present and Future Treatments for Retinal Degenerative Diseases: An Overview Gerald J. Chader Doheny Retina Institute USC Medical School Los Angeles, CA.
Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.
Retinitis Pigmentosa Paulette Frank, Amy Hayes, Monica Johnson, and Michelle Parker.
Volume 2, Issue 1, (January 2013)
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Gene Therapy in Retinitis Pigmentosa (RP) Henry J Kaplan, MD Evans Professor of Ophthalmology Chair, Department of Ophthalmology & Visual Sciences Director,
Retinitis Pigmentosa (RP)
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
Acute Macular Neuroretinopathy
AAV-mediated Gene Therapy Restores Cone Function In A Rat With An M-cone Opsin Deficiency, A Model For Blue Cone Monochromacy Purpose: Using an AAV vector.
Usher Syndrome By Andy Beer. What is Usher Syndrome Usher Syndrome is a genetic disease on witch you lose the ability to hear and see. The major symptoms.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: An Unusual Retinal Phenotype Associated With a Novel.
Date of download: 6/1/2016 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved. From: Optical Coherence Tomography.
Date of download: 7/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Management of Autoimmune Retinopathies With Immunosuppression.
My sisters keeper trailer
Usher syndrome By Andy Beer.
From: Retinoic Acid Promotes Apoptosis and Differentiation in Photoreceptors by Activating the P38 MAP Kinase Pathway Invest. Ophthalmol. Vis. Sci ;54(5):
Two-Step Reactivation of Dormant Cones in Retinitis Pigmentosa
INTRAVITREAL INJECTION OF
Invest. Ophthalmol. Vis. Sci ;54(9): doi: /iovs Figure Legend:
From: Efficient Gene Transfer into Retinal Cells Using Adenoviral Vectors: Dependence on Receptor Expression Invest. Ophthalmol. Vis. Sci ;45(6):
From: Deficiency of SHP-1 Protein-Tyrosine Phosphatase in “Viable Motheaten” Mice Results in Retinal Degeneration Invest. Ophthalmol. Vis. Sci ;47(3):
From: A Frameshift Mutation in RPGR Exon ORF15 Causes Photoreceptor Degeneration and Inner Retina Remodeling in a Model of X-Linked Retinitis Pigmentosa.
From: Polarized Secretion of PEDF from Human Embryonic Stem Cell–Derived RPE Promotes Retinal Progenitor Cell Survival Invest. Ophthalmol. Vis. Sci ;52(3):
Jackson, Jefferson, Klecka, Castillo
Topic 1.1 – Stem Cells and Differentiation
Retinitis Pigmentosa Owen Ferrara.
STEM CELLS Mesenchymal precursor cells
Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
Volume 21, Issue 6, Pages (June 2013)
Vision Science: Can Rhodopsin Cure Blindness?
Vision Science: Can Rhodopsin Cure Blindness?
Activation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by AAV Gene Transfer Protects Retinal Ganglion Cells in Glaucoma  Yu Zhou, Vincent.
Two-Step Reactivation of Dormant Cones in Retinitis Pigmentosa
Volume 4, Issue 6, Pages (December 2001)
Volume 19, Issue 2, Pages (February 2011)
Volume 4, Issue 5, Pages (November 2001)
Neural Regeneration and Cell Replacement: A View from the Eye
Volume 17, Issue 5, Pages (May 2009)
Retinitis Pigmentosa Course Title : Molecular diagnostic Unit : II
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
Volume 20, Issue 4, Pages (April 2012)
Depicting brighter possibilities for treating blindness
Fig. 1 Relevance of therapies for treating retinal degeneration and stage of disease. Relevance of therapies for treating retinal degeneration and stage.
Presentation transcript:

Two-step Reactivation of Dormant Cones in Retinitis Pigmentosa Henry J Kaplan, MD Evans Professor of Ophthalmology Chair, Ophthalmology & Visual Sciences Director, KY Lions Eye Center University of Louisville 25th Iranian Congress of Ophthalmology2015

Collaborators UofL Ophthalmology NSRRC Iowa State University Faculty Doug Dean Maureen McCall Wei Wang Patrick Scott Paul DeMarco Kaplan Research team Sang Joon Lee Xiaoqin Lu Douglas Emery Yongqin Liu Eric Vukmanic Juan Fernandez de Castro NSRRC Randall Prather Eric Walters Iowa State University Jason Ross Missouri U Toshiko Ezashi Michael R Roberts U Florida William Hauswirth Al Lewin UC Berkeley John Flannery

Retinitis Pigmentosa Classic fundus presentation Attenuated retinal vessels Mottling/granularity of RPE Bone-spicule intraretinal pigmentation Optic nerve head pallor Clinical symptoms – night blindness, constricted peripheral visual field Diagnostic testing – abnormal full-field ERG recordings

Functional Vision Loss Occurs with Cone Dysfunction and Death Most RP mutations occur in rod-specific photoreceptor genes leading to progressive rod destruction, and the loss of peripheral vision and dark adaptation However, it is the subsequent loss of cone function, marked by the sequential loss of the visual pigment-rich cone OS and mitochondrial-rich cone IS that results in severe functional visual impairment

Overview Transplantation of stem cells to replace degenerated rods in RP and restore rod vision may not be possible Primary reason the number of cells required for rod vision may not be achievable since < 5% of transplanted cells integrate into the ONL However, functional blindness in RP begins with loss of cone function We asked the question whether rod stem cell transplantation could prevent cone loss, and even rescue degenerated cones

Concept of Cone Dormancy As rods lose function and die, cones rapidly lose synthesis of their cone OS, and thus, central (i.e. macula) visual function Subsequently, cone IS that are critical for aerobic metabolism, disassemble Yet despite this loss of cone IS there is long-term persistence of cone cell bodies in RP retinas in a non-functional state (i.e. dormant cones).

Novel Hypothesis – Loss of cone function is a 2-step process and is amenable to treatment These dormant cones can regenerate IS and OS following stem cell transplantation Although NP agents, such as RdCVF, may delay the onset of cone dormancy, they can’t reactivate dormant cones – i.e. they can’t reassemble cone IS and regenerate cone OS However, the persistence of dormant cones in RP raises the possibility of regeneration of cone IS and synthesis of cone OS synthesis to maintain or restore lost central vision

Generation of a model of Pro23His (P23H) Retinopathy in the Pig Autosomal dominant RP is the most common inheritance pattern (~30% of cases) P23H mutation in Rhodopsin (RHO) most common form of autosomal dominant RP in North America Somatic cell nuclear transfer - transgenic model Ross et al. Invest Ophthalmol Vis Sci (IOVS) 2012; 53(1):501

Why use the pig as a model of cone dormancy in RP? The study of dormant cones needs to occur in a species where there is an area of high cone density in the retina The visual streak of the pig, analogous to the macula of man is such an area located ~ 2.5 mm superior to the optic disc Somatic cell nuclear transfer - transgenic model Ross et al. Invest Ophthalmol Vis Sci (IOVS) 2012; 53(1):501

Clinical phenotype of P23H retinopathy in pig P Scott et al. IOVS 2014 4;55:2452–2459 Morphology Wt P23H P23H swine at P3 lack ROS; CIS appear enlarged; COS (black arrows) abut the RPE; the ONL is thinner Rapid loss of rod PR in ONL by P30, with loss of RHO expression in the few remaining rod nuclei By P60, there are only cone PR nuclei in ONL

Clinical phenotype of P23H retinopathy in pig ff ERG JP Fernandez de Castro et al. IOVS 2014 55:2460–2468 At P0, there is no scotopic (i.e. rod) ERG in P23H retinopathy, in contrast to Wt However, the photopic (i.e. cone) ERG in P23H retinopathy matures normally until P30, and then responses decline P30 P90

Retinal Stem Cells Used for Transplantation Three types of stem cells being studied ESC (embryonic stem cells) Fetal retinal progenitor cells (E65) Swine retinal progenitor cells (NSRRC – Univ Missouri) iPSC (induced pluripotent stem cells) Swine iPSC (M Roberts ) Gestational cycle ~ 115 days for pigs; we have used fetal cells at various time points from E45-E105 for transplantation iPSC were differentiated in vitro to express rod photoreceptor cell markers and then transplanted

Technique of stem cell transplantation beneath retina in pig Zhou et al. Stem Cells 2011; 29:972

Method of counting of cone nuclei and OS The number of cone nuclei and OS were counted along the visual streak as a function of distance from the site of transplantation (injection bleb) in retinal sections in 200 µm lengths from the margin of the bleb to 2000 µm distal.

Three Stages of Cone Dormancy in Our Pig of P23H Retinopathy P14 – analogous to onset of central vision loss in RP in man Rods are lost, cone OS are malformed P60 – analogous to poor central vision in man Rods are lost, cone OS are lost, but cone IS are maintained P120 – analogous to end-stage of central vision in man Rods are lost, cone OS are lost and cone IS collapse

Transplanted stem cells preserved cone OS at P14 When we transplanted E65 or rod-differentiated iPSCs into the SRS at P14 (rods lost, cone OS malformed) there was regeneration of cone OS and an enhanced mfERG response ≤ 1000μ from the transplant at P60 (rods lost, cone OS lost)

P23H Retinopathy Transplanted at P14 and Assessed at P60

Transplanted stem cells regenerated cone IS and OS at P120 When E65 or rod-differentiated iPSCs were transplanted at P120 (after rods and cone OS lost, cone IS collapsed) there was regeneration of both cone IS and OS, as well as an increased mfERG response function ≤ 1400μ

P23H Retinopathy Transplanted at P120 and Assessed at P155

Additionally, cone IS assembly and OS synthesis are separate functions Transplanted rods triggered both IS reassembly and reactivation of OS in dormant cones But IS reassembly extended farther beyond reactivation of OS synthesis Implying these are separable functions of the transplanted rods

Cone Dormancy can be Reversed and Central Vision Recovered Step 1: Cone IS reassembly Rods initially transmit a signal for reassembly of the ER and mitochondria into a polarized mitochondrial-rich IS Step 2: Cone OS synthesis Mitochondrial-based aerobic metabolism is returns for fatty acid synthesis and cone OS formation Since cones lose OS synthesis well before IS disassembly, therapies aimed at reversing decreased aerobic metabolism might preserve cone function prior to end-stage IS loss. But ultimately reversal of IS loss, e.g. by rod-differentiated iPSC transplants, may be possible

Conclusions Swine model of P23H retinopathy suggests a 2-step process for reactivation of dormant cones Step 1, reassembly of cone IS, is dependent on rod progenitor cells and/or rod-differentiated iPSCs Step 2, cone OS synthesis, is dependent on induced aerobic metabolism Recognition of this 2-step process suggests multiple potential translational interventions

Thank you!

Sahel Hypothesis Ait-Slu N et al. Cell 2015 Circulating GL in the choroid is transported to the subretinal space by the RPE, and then is taken up by a Bsg/Glut1 complex on cone IS Recent mouse studies show that RdCVF (a thioredoxin) binds Bsg1/Glut1 on cone IS to promote GL uptake in vitro

RdCVF doesn’t reverse cone dormancy Although, overexpression of RdCVF in the SRS in murine RP delays cone OS loss and function The NP effect of RdCVF doesn’t reverse cone dormancy Bryne LC et al. JCI 2015 RdCVF1 ko (Nxnl1) mice display normal cone EP function until 12 mos These results suggest that RdCVF is not essential for cone development or function until perhaps challenged by oxidative stress

Transplanted stem cells Multifocal ERG Response Density Maps After Transplantation in P23H Retinopathy 4 weeks post-surgery OD Transplanted stem cells OS BSS Control Therefore, not only is cone morphology rescued/regenerated but electrical function as well